Early detection of poor lung health may save cost, but more importantly, may save lives. SQI Diagnostics has produced the Health Canada authorized test, RALI-Dx™ IL-6 Severity Triage Test, to speed the assessment of COVID respiratory illness patients in the Emergency Room.

Contact us today to learn more about RALI-Dx™
About RALI-Dx™

The Rapid Acute Lung Injury Diagnostic (RALI-Dx™*) IL-6 Severity Triage Test is an in vitro diagnostic test for the quantitative measurement of IL-6 (Interleukin 6) in human plasma (potassium EDTA). RALI-Dx™ is a fluorescent immunoassay and is intended for use on the sqidlite® instrument. It is used to assist in identifying severe inflammatory responses in patients (age ≥18 years) with confirmed COVID-19 illness by a healthcare provider and to aid in determining the risk of intubation with mechanical ventilation.

Normal IL-6 results do not preclude development of a severe inflammatory response, and IL-6 should not be used as the sole basis for patient management decisions. Results must be combined with clinical observations, patient history, other laboratory parameters and epidemiological information.

The RALI-Dx™ IL-6 Severity Triage Test is only for use under Health Canada’s Interim Order, for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of in vitro diagnostic procedures, for use by health care providers, for prescription use only, and for in vitro diagnostic use only.

*Not currently cleared or authorized by FDA.

Use in Hospitals

With a short turnaround time of 90 minutes or less, RALI-Dx™ may assist with a huge unmet public health need. As COVID-19 continues to affect the world, RALI-Dx™ could be an important tool in hospitals to assist in identifying severe inflammatory response of patients as early as possible to detect and identify cases most at risk of mechanical ventilation to treat them accordingly.

Similarly, other less critical patients could be ruled out and evaluated for safe discharge using RALI-Dx™ in concert with other clinical assessment tools. Patient flow and Hospital Emergency Department resources could be dramatically impacted with effective use of advanced respiratory diagnostic tools like RALI-Dx™.


Rali-Dx fast

Under development for point of care (POC). Not cleared by FDA or licensed by Health Canada.

RALI-fast (15-Minute POC Test)